However, the synthesis of highly selective or isoform-specific inhibitors that reduce unwanted side effects still remains challenging
was supported by a Wellcome Trust Senior Investigator Award (WT098424AIA), MRC Program grants (MR/J0003042/1, MR/L020149/1) and Experimental Challenge Grant (DIVA, MR/L02036X/1), BBSRC (BB/J015873/1), MRC (MR/N00275X/1), Diabetes UK (BDA/11/0004210, BDA/15/0005275, BDA 16/0005485) and Imperial Confidence in Concept (ICiC) grants, and a Royal Society Wolfson Research Merit Award
The article states it flatly in a table cell with no study, population, or effect size behind it, and prediction is a strong word for an inflammatory marker with no established role in dose selection
Heres a rundown of what to avoid to help you stay on track with your treatment